Total Payments
$6,465
2024 Payments
$191.91
Companies
45
Transactions
259
Medicare Patients
8,829
Medicare Billing
$820,945
Payment Breakdown by Category
Food & Beverage$5,563 (86.1%)
Travel$787.30 (12.2%)
Other$114.33 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,563 | 254 | 86.1% |
| Travel and Lodging | $787.30 | 4 | 12.2% |
| Entertainment | $114.33 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,956 | 55 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $580.48 | 27 | $0 (2024) |
| Medtronic Vascular, Inc. | $403.39 | 9 | $0 (2019) |
| Abbott Laboratories | $399.09 | 11 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $392.66 | 41 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $244.28 | 18 | $0 (2024) |
| Cardiovascular Systems Inc. | $219.01 | 1 | $0 (2017) |
| Terumo Medical Corporation | $214.38 | 1 | $0 (2017) |
| Amgen Inc. | $191.59 | 13 | $0 (2023) |
| Inari Medical, Inc. | $173.90 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $191.91 | 10 | Novo Nordisk Inc ($57.70) |
| 2023 | $617.49 | 20 | Boston Scientific Corporation ($199.04) |
| 2022 | $569.06 | 24 | Boston Scientific Corporation ($210.72) |
| 2021 | $617.43 | 48 | Janssen Pharmaceuticals, Inc ($124.08) |
| 2020 | $616.47 | 34 | Hitachi Healthcare Americas Corp. ($114.33) |
| 2019 | $1,531 | 35 | Boston Scientific Corporation ($1,031) |
| 2018 | $701.75 | 38 | BOSTON SCIENTIFIC CORPORATION ($191.39) |
| 2017 | $1,620 | 50 | Abbott Laboratories ($282.56) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Not Applicable | ||||||
| 02/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 02/08/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Cardiology | ||||||
| 01/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.80 | General |
| Category: Cardiovascular | ||||||
| 01/29/2024 | Medtronic, Inc. | TYRX (Device) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Antibacterial Mesh | ||||||
| 01/26/2024 | Boston Scientific Corporation | INGEVITY MRI (Device) | Food and Beverage | In-kind items and services | $33.30 | General |
| Category: Ingevity MRI_CRM | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/24/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/21/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: LUX-Dx_CRM | ||||||
| 11/15/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $173.90 | General |
| Category: VTE | ||||||
| 11/10/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: General - Tachy_CRM | ||||||
| 10/20/2023 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: DEVICES | ||||||
| 10/20/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.81 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/11/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $92.71 | General |
| Category: LUX-Dx_CRM | ||||||
| 08/30/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Cardiology | ||||||
| 06/29/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/16/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $13.66 | General |
| Category: Medical Device | ||||||
| 05/30/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: Cardiovascular | ||||||
| 05/24/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $40.20 | General |
| Category: LUX-Dx_CRM | ||||||
| 05/12/2023 | Boston Scientific Corporation | EMBLEM MRI S-ICD (Device) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: EMBLEM_CRM | ||||||
| 05/09/2023 | Medtronic, Inc. | TELESCOPE (Device) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Catheters | ||||||
| 05/02/2023 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: DEVICES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,842 | 2,518 | $709,297 | $172,603 |
| 2022 | 37 | 2,324 | 3,111 | $860,187 | $203,718 |
| 2021 | 44 | 2,435 | 3,237 | $983,951 | $240,336 |
| 2020 | 37 | 2,228 | 3,050 | $660,015 | $204,288 |
Total Patients
8,829
Total Services
11,916
Medicare Billing
$820,945
Procedure Codes
167
All Medicare Procedures & Services
167 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 332 | 505 | $155,540 | $41,752 | 26.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 124 | 140 | $61,880 | $17,340 | 28.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 49 | 51 | $53,448 | $15,409 | 28.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 105 | 114 | $53,580 | $14,805 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 243 | $52,974 | $14,257 | 26.9% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 49 | 102 | $29,580 | $9,018 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 126 | $23,369 | $7,477 | 32.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 36 | 152 | $18,848 | $6,597 | 35.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 63 | 113 | $19,339 | $5,797 | 30.0% |
| 37238 | Insertion of stent in vein with review by radiologist, initial vein | Facility | 2023 | 23 | 23 | $51,704 | $5,175 | 10.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $18,941 | $5,100 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 78 | 86 | $40,420 | $3,996 | 9.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 33 | $10,791 | $3,150 | 29.2% |
| 37239 | Insertion of stent in vein with review by radiologist, each additional vein | Facility | 2023 | 23 | 23 | $25,691 | $2,546 | 9.9% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Facility | 2023 | 25 | 25 | $5,105 | $1,649 | 32.3% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 12 | 22 | $4,740 | $1,382 | 29.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 18 | 18 | $5,400 | $1,349 | 25.0% |
| 37253 | Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | Facility | 2023 | 25 | 25 | $4,018 | $1,309 | 32.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 29 | 61 | $4,042 | $1,308 | 32.4% |
| 75822 | Review by radiologist of both arms and legs veins of both arms or legs image | Facility | 2023 | 24 | 24 | $4,584 | $1,249 | 27.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,304 | $1,172 | 27.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 40 | 79 | $3,858 | $1,155 | 29.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 97 | 110 | $3,740 | $1,111 | 29.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 23 | 23 | $3,864 | $1,001 | 25.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 54 | 54 | $3,856 | $981.24 | 25.4% |
About Dr. Kevin Ryan, MD
Dr. Kevin Ryan, MD is a Cardiovascular Disease healthcare provider based in Opelika, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033137641.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Ryan, MD has received a total of $6,465 in payments from pharmaceutical and medical device companies, with $191.91 received in 2024. These payments were reported across 259 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($5,563).
As a Medicare-enrolled provider, Ryan has provided services to 8,829 Medicare beneficiaries, totaling 11,916 services with total Medicare billing of $820,945. Data is available for 4 years (2020–2023), covering 167 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Opelika, AL
- Active Since 07/18/2006
- Last Updated 09/10/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033137641
Products in Payments
- ANGIOJET (Device) $845.61
- XARELTO (Drug) $379.45
- OPSUMIT (Drug) $339.89
- LUX-Dx Insertable Cardiac Monitor (Device) $324.57
- CardioMEMS HF System (Device) $270.09
- UPTRAVI (Drug) $240.59
- Peripheral Orbital Atherectomy System (Device) $219.01
- ENTRESTO (Drug) $216.23
- Navicross (Device) $214.38
- VenaSeal (Device) $177.73
- FLOWTRIEVER CATHETER, S (Device) $173.90
- IN.PACT Admiral (Device) $172.18
- MULTAQ (Drug) $141.61
- Supera peripheral stent system (Device) $129.00
- Repatha (Biological) $121.51
- CAMZYOS (Drug) $116.88
- LATITUDE (Device) $115.09
- EMBLEM (Device) $113.06
- GENERAL VASCULAR INTERVENTION (Device) $95.00
- TRELEGY ELLIPTA (Drug) $94.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Opelika
Michael Aikens, Md, MD
Cardiovascular Disease — Payments: $16,191
Cardiovascular Disease $16,191
Dr. David Holmes, Md, MD
Cardiovascular Disease — Payments: $14,573
Cardiovascular Disease $14,573
Dr. Allan Schwadron, Md, MD
Cardiovascular Disease — Payments: $13,661
Cardiovascular Disease $13,661
Dr. Donald Rhodes, Md, MD
Cardiovascular Disease — Payments: $6,779
Cardiovascular Disease $6,779